新生儿喉镜前预用药的前瞻性多中心观察研究
结果显示,非危及生命的插管中90.1%使用了预用药,但仅42.7%符合SFN指南;非紧急插管和无血流动力学障碍是指南依从性的独立相关因素。
要点
- 非危及生命插管中90.1%使用预用药,但仅42.7%符合SFN指南。
- 非紧急插管与指南依从性独立相关(aOR 3.1,95%CI 1.4-7.0)。
- 无血流动力学障碍与指南依从性独立相关(aOR 31.0,95%CI 6.4-150.3)。
核心结论
- 约90%的非危及生命喉镜操作使用了预用药,但不足半数符合SFN指南。
- 非紧急插管和无血流动力学障碍与指南依从性独立相关。
研究设计与样本
- 前瞻性、多中心、观察性队列研究,在141个法国和比利时新生儿病房开展。
- 主要结局为预用药与SFN指南一致的比例,采用多因素混合效应logistic回归分析相关因素。
主要发现
- 506例插管中,110例(21.7%)为即刻危及生命的紧急情况。
- 396例非危及生命插管中,357例(90.1%)使用了预用药,其中169例(42.7%)符合SFN指南。
- 符合SFN指南的预用药包括单独丙泊酚(n=149,37.6%)和速效阿片类+肌松剂(n=20,5.1%)。
- 167例微创肺表面活性物质给药中,151例(90.4%)使用了特定预用药,包括丙泊酚(n=84,50.3%),符合SFN指南。
关键数值与推荐
- 非紧急插管与指南依从性独立相关(aOR 3.1,95%CI 1.4-7.0)。
- 无血流动力学障碍与指南依从性独立相关(aOR 31.0,95%CI 6.4-150.3)。
- 插管前最常用的预用药为丙泊酚和氯胺酮,其次为阿片类和/或麻醉药。
临床怎么用
- 在非危及生命的新生儿喉镜操作中,应参照SFN指南选择预用药方案以提高指南依从性。
- 非紧急插管和无血流动力学障碍时更易实现指南依从,临床可据此优化预用药决策。
局限性
- 研究为观察性设计,仅评估指南依从性,未评估预用药的疗效和耐受性。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the implementation of the 2023 French Society of Neonatology (SFN) guidelines for premedication before laryngoscopy in neonates without life-threatening emergencies. STUDY DESIGN: A prospective, observational cohort study was conducted across 141 French and Belgian neonatal units. Laryngoscopy data from intubation or less invasive surfactant administration in neonates <45 weeks postmenstrual age were collected. The primary outcome was the proportion of premedication consistent with SFN guidelines. Factors associated with guideline compliance were analyzed using multivariable mixed-effects logistic regression adjusted for neonatal and procedural characteristics. RESULTS: Six hundred seventy-three laryngoscopies were included. The mean (SD) gestational age was 30.1 (4.8) weeks. Of 506 intubations, 110 (21.7%) were immediate life-threatening emergencies. Among 396 non-life-threatening intubations, 357 (90.1%) were preceded by premedication with 169 (42.7%) consistent with SFN guidelines (propofol alone [n = 149, 37.6%]; a fast-acting opioid + muscle blocker [n = 20, 5.1%]). Independent factors associated with SFN guidelines compliance were non-emergent intubation (adjusted odds ratio 3.1 [95% CI 1.4-7.0]) and absence of hemodynamic compromise (adjusted odds ratio 31.0 [95% CI 6.4-150.3). Propofol and ketamine were the most frequent premedications before intubation, followed by opioids and/or anesthetics. Of the 167 less invasive surfactant administration procedures, 151 (90.4%) were preceded by a specific premedication including propofol (n = 84, 50.3%), consistent with SFN guidelines. CONCLUSIONS: Ninety percent of non-life-threatening laryngoscopies were preceded by a premedication but fewer than half complied with SFN guidelines. Further studies on efficacy and tolerance of neonatal anesthetics and drugs associations are needed.
引用
- Tauzin M, Tribolet S, Goro S, et al. A Prospective, Multicenter, Observational StUdy of PREMEdication Before Laryngoscopy in NEOnates (SUPREMEneo). J Pediatr. 2025. PMID: 41429284. doi:10.1016/j.jpeds.2025.114967
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。